Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients

Support Care Cancer. 2001 May;9(3):209-10. doi: 10.1007/s005200000194.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use
  • Aspergillosis / drug therapy*
  • Child
  • Female
  • Fluconazole / therapeutic use
  • Humans
  • Liposomes
  • Lung Diseases, Fungal / drug therapy*
  • Male
  • Middle Aged
  • Neoplasms / complications*
  • Nystatin / administration & dosage*
  • Nystatin / adverse effects
  • Treatment Failure
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Liposomes
  • Nystatin
  • Amphotericin B
  • Fluconazole